Experience and challenges presented by a multicenter crossover study of combination analgesic therapy for the treatment of painful HIV-associated polyneuropathies - Wikidata - awgldk - TriplyDB

Experience and challenges presented by a multicenter crossover study of combination analgesic therapy for the treatment of painful HIV-associated polyneuropathies

Experience and challenges presented by a multicenter crossover study of combination analgesic therapy for the treatment of painful HIV-associated polyneuropathies

http://www.wikidata.org/entity/Q34392451

about

Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia Understanding the etiology and management of HIV-associated peripheral neuropathy.Drug combinations in the treatment of neuropathic pain.Update of HIV-Associated Sensory Neuropathies.Diagnosing and treating HIV-associated sensory neuropathy: a global perspective.2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV.Improved therapeutic potential of tapentadol employing cationic exchange resins as carriers in neuropathic pain: evidence from pharmacokinetic and pharmacodynamics study.

P2860

Q24201220-61317CA7-F1AA-4186-8D44-06AB1A8A5AD8 Q38223573-F60D2680-747F-4A63-A9D9-AF763240DAD7 Q38258294-478BFF5A-A551-413D-A7E8-D0005D3E197B Q38598335-8E1AF2D0-0A31-4B39-B2B6-E2094126CB74 Q38778861-E3E6563F-FC5C-40B7-A330-2E79FAB97C5B Q41919082-E6C0E61F-3DA9-433D-9C57-1CC4638EF5A1 Q50046149-0AF27085-DDA5-4984-8D0F-2D9A95FD31F3

P2860

Experience and challenges presented by a multicenter crossover study of combination analgesic therapy for the treatment of painful HIV-associated polyneuropathies

http://www.wikidata.org/entity/Q34392451

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Experience and challenges pres ...... IV-associated polyneuropathies

@ast

Experience and challenges pres ...... IV-associated polyneuropathies

@en

Experience and challenges pres ...... IV-associated polyneuropathies

@nl

type

label

Experience and challenges pres ...... IV-associated polyneuropathies

@ast

Experience and challenges pres ...... IV-associated polyneuropathies

@en

Experience and challenges pres ...... IV-associated polyneuropathies

@nl

prefLabel

Experience and challenges pres ...... IV-associated polyneuropathies

@ast

Experience and challenges pres ...... IV-associated polyneuropathies

@en

Experience and challenges pres ...... IV-associated polyneuropathies

@nl

P1433

Q34392451-4F4BA7C1-C449-47D8-94F9-4C62DEF83235

P1476

Q34392451-911FC78F-9C12-4C48-9D83-7CB03FC86731

P2093

Q34392451-1371654B-1ED3-4293-9363-A9911F071008

Q34392451-2C965539-9E6F-4AE1-825A-1778DE0F258D

Q34392451-6F82A8B7-13BB-4F0D-84A0-B26D0137DE8E

Q34392451-974DC384-AC62-4E67-AEBB-07D402860727

Q34392451-9DE167C7-B4D2-4387-B2FE-380197DDB05C

Q34392451-A24928DB-381B-4B76-BC27-CE494A6D3751

Q34392451-BB7313DE-04BD-4A39-9B64-A9977D93E748

Q34392451-BE1F9401-DA26-4C8D-B413-B1599F0C33FB

Q34392451-BFDF8605-6EB1-450D-BEA8-BDA4C2FD97CB

Q34392451-C70DF5AC-5525-49B7-9466-BE6DA5DC2639

P2860

Q34392451-072D48D5-E0D2-4DA0-B872-7CF30799951F

Q34392451-1008307E-740C-4B92-8121-276D71110408

Q34392451-172769F8-EC39-49C0-83F9-814FF949E26E

Q34392451-2E3FC582-2E08-42A6-AF74-C9DE23DA0763

Q34392451-4BF3FAA5-4BB4-4857-9619-40F94C5F89FE

Q34392451-4D6CF624-915E-413C-86FB-61CD68EA132E

Q34392451-53C7DB41-6424-46E5-BF90-4BA5E93B9C70

Q34392451-54E540D5-BC60-4E58-80AA-872EA182F064

Q34392451-5AC6FB57-5748-4236-8857-CB85DF33BE27

Q34392451-5B8F37FA-B007-4455-9151-4A8FBC4FF78D

P304

Q34392451-5FF17EA2-7045-4698-BC3D-2618326AC250

P31

Q34392451-89026791-759C-404B-BE0F-5BC96A16FED4

P356

Q34392451-78D69C8A-E93E-41F2-AD16-84200F545127

P433

Q34392451-2831B7B7-FAA1-45A6-901A-3F84A66E80FF

P478

Q34392451-DEE0741B-897D-4A4A-9378-62BAA252420A

P577

Q34392451-8FA1C07C-58F6-4653-A3DE-3088256CD009

P698

Q34392451-B64B1ADF-9281-4B58-B69D-A342B2FFF021

P932

Q34392451-9A1AE1F5-21D5-4E94-ACAE-AB76FA801060

P356

P1433

P1476

Experience and challenges pres ...... IV-associated polyneuropathies

@en

P2093

ACTG A5252 Team

http://www.w3.org/2001/XMLSchema#string

Anthony Lee

http://www.w3.org/2001/XMLSchema#string

Barbara Bastow

http://www.w3.org/2001/XMLSchema#string

David B Clifford

http://www.w3.org/2001/XMLSchema#string

David Simpson

http://www.w3.org/2001/XMLSchema#string

Eric S Daar

http://www.w3.org/2001/XMLSchema#string

Ian Gilron

http://www.w3.org/2001/XMLSchema#string

Linda Wieclaw

http://www.w3.org/2001/XMLSchema#string

Robert Dworkin

http://www.w3.org/2001/XMLSchema#string

Sachiko Miyahara

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials

HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank.

Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial.

Meta-analysis of the relationship between HIV infection and risk for depressive disorders.

The evidence for pharmacological treatment of neuropathic pain.

A flood of opioids, a rising tide of deaths.

Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy

Morphine, gabapentin, or their combination for neuropathic pain.

Duloxetine vs. placebo in patients with painful diabetic neuropathy.

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.

P304

1039-1047

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PME.12084

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23565581

http://www.w3.org/2001/XMLSchema#string

P932

4207215

http://www.w3.org/2001/XMLSchema#string